Cellosaurus SpESF (CVCL_WS48)
Cell line name | SpESF | |
---|---|---|
Synonyms | SpEEE Serum-Free | |
Accession | CVCL_WS48 | |
Resource Identification Initiative | To cite this cell line use: SpESF (RRID:CVCL_WS48) | |
Comments | Group: Hybridoma fusion partner cell line. Group: Patented cell line. Group: Serum/protein free medium cell line. Characteristics: Transfected with a hBCL2-EEE-pZeoSV2+ construct. Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine. Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2 (Note=With p.Thr69Glu, p.Ser70Glu and p.Ser87Glu = BCL2-EEE). Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR). | |
Disease | Mouse plasma cell myeloma (NCIt: C125417) | |
Species of origin | Mus musculus (Mouse) (NCBI Taxonomy: 10090) | |
Hierarchy | Parent: CVCL_WS47 (SpEEE) Children:
| |
Sex of cell | Female | |
Category | Cancer cell line | |
Publications | Patent=US7608425 PubMed=21473000; DOI=10.1002/btpr.584 | |
Cross-references | ||
Encyclopedic resources | Wikidata; Q98132814 | |
Entry history | ||
Entry creation | 05-Jul-2019 | |
Last entry update | 19-Dec-2024 | |
Version number | 6 |